Benzodiazepine:Short-term use in anxiety or insomnia Status epilepticus Perioperative
DOSE IN NORMAL RENAL FUNCTION
Anxiety: 1–4 mg daily in divided doses Insomnia associated with anxiety: 1–2 mg at bedtimeAcute panic attacks: (IV/IM): 25–30 mcg/ kg; repeat 6 hourly if required; usual range 1.5–2.5 mgStatus epilepticus: 4 mg IV repeated once after 10 minutes
Volume of distribution (L/kg)       :0.9–1.3
half-life – normal/ESRD (hrs)      :
10 to 20
/32–70
DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Dose as in normal renal function
10 to 20     : Dose as in normal renal function
<10           : Dose as in normal renal function
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Unlikely dialysability. Dose as in normal renal function.
HD                     :Not dialysed. Dose as in normal renal function
HDF/high flux   :Unknown dialysability. Dose as in normal renal function
CAV/VVHD      :Not dialysed. Dose as in normal renal function
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Antibacterials: metabolism possibly increased by rifampicin
Antipsychotics: increased sedative effects; increased risk of hypotension, bradycardia and respiratory depression when parenteral benzodiazepines are given with IM olanzapine
Antivirals: concentration possibly increased by ritonavirDisulfiram: metabolism inhibited, increased sedative effectsSodium oxybate: enhanced effects of sodium oxybate – avoid
Ulcer-healing drugs: metabolism inhibited by cimetidine
ADMINISTRATION
Reconstition
Route
Oral, IV, IM, sublingual
Rate of Administration
Slow IV bolus
Comments
Onset of effect after IM injection is similar to oral administrationIV route preferred over IM route Dilute 1:1 with sodium chloride 0.9% or water for injectionCan be used undiluted. (UK Critical Care Group, Minimum Infusion Volumes for fluid restricted critically ill patients, 3rd Edition, 2006)
OTHER INFORMATION
Patients with impaired renal or hepatic function should be monitored frequently and have their dosage adjusted carefully according to response. Lower doses may be sufficient in these patientsLorazepam as intact drug is not removed by dialysis. The glucuronide metabolite is highly dialysable, but is pharmacologically inactiveIncreased CNS sensitivity in patients with renal impairment.